Why AgeX Therapeutics, Inc. (AGE) Shares Are Crashing -12.46 Percent Today

AgeX Therapeutics, Inc. (NYSE:AGE) is one of the worst performers on the stock market today. At current price of $3.5, the shares have already lost -0.5 points (-12.46% lower) from its previous close of $4. Should you buy or avoid them? The stock sets an active trading volume day with a reported 211134 contracts so far this session. AGE shares had a relatively better volume day versus average trading capacity of 67.67 million shares, but with a 21.22 million float and a -12.85% run over a week, it’s definitely worth keeping an eye on. AGE share price has been trading recently between $4 and $4.8.

The most recent news story about the stock that appeared in Yahoo Finance‘s news section was titled “AgeX Therapeutics Reports First Quarter 2019 Financial Results and Provides Business Update” and dated May 15, 2019.

Looking at the current readings for AgeX Therapeutics, Inc., the two-week RSI stands at 33.21. This figure suggests that AGE stock, for now, is neutral, meaning that the shares are stable in terms of price movement. The stochastic readings, on the other hand, based on the current AGE readings is similarly very revealing as it has a stochastic reading of 38.56% at this stage. This figure means that AGE share price today is being neutral.

Technical chart claims that AgeX Therapeutics, Inc. (AGE) would settle between $4.53/share to $5.07/share level. However, if the stock price goes below the $3.73 mark, then the market for AgeX Therapeutics, Inc. becomes much weaker. If that happens, the stock price might even plunge as low as $3.47 for its downside target. The stock is currently in the red zone of MACD, with the indicator reading -0.42. Traders are always alerted for the move of a stock above or below the zero line due to the fact that the reading is an indicator of the position of the short-term average relative to the long-term average. If the MACD is above the zero line, then the short-term average relative is above that of the long-term average, thus implying an upward momentum. Vice versa is the case if the MACD is below the zero line.